Dyslipidemia in cohorts of rheumatoid arthritis presented at Independent University Hospital Faisalabad.
DOI:
https://doi.org/10.29309/TPMJ/2024.31.08.8287Keywords:
Cardiovascular, Dyslipidemia, Disease Modifying Anti-rheumatic Drugs, Methotrexate, Rheumatoid ArthritisAbstract
Objective: To determine the frequency of dyslipidemia in RA patients and its association with different factors i.e., age, gender, disease duration and disease score. Study Design: Cross Sectional study. Setting: Independent University Hospital Faisalabad. Period: January 2022 to December 2023. Methods: 200 consecutive RA patients fulfilling inclusion and exclusion criteria, of either sex between age of 20 and 60 years were enrolled. The selection technique was non-probability convenient in this study. Frequency of dyslipidemia was assessed by the National Education Cholesterol Program 2004. The Chi square test was used to compare the frequency of dyslipidemia among different disease scores, different disease duration groups, age groups and gender. A p-valve of < 0.05 was considered statistically significant. Results: The frequency of dyslipidemia in RA patients was assessed. It was more common in female gender and age group of 36-50 years and of moderate disease score, also negative association of dyslipidemia was found when compared with different gender groups. Conclusion: Dyslipidemia, which is an important risk factor for CV diseases, was more prevalent in RA patients. High disease activity and more chronic disease are important association factors in dyslipidemia in RA patients.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 The Professional Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.